Clinical trial

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

NCT06144593

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Dietary macronutrient composition Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-01-03

PhaseNA

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Overweight and Obesityunresolved

Non-Alcoholic Fatty Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Interventions

Dietary macronutrient compositionOTHER

Sponsors & collaborators

Hvidovre University Hospitallead sponsor

University of Copenhagencollaborator

Danish Research Centre for Magnetic Resonancecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06144593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.